IMMUNITYBIO, INC. Payments of Stock Issuance Costs
IMMUNITYBIO, INC. (IBRX) had Payments of Stock Issuance Costs of $4.60 million as of 2025-07-28, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-02-23
- 2025-07-28: Payments of Stock Issuance Costs $4.60M.
- 2025-07-24: Payments of Stock Issuance Costs $4.60M.
- 2025-04-07: Payments of Stock Issuance Costs $200.00K.
| Period end | Payments of Stock Issuance Costs |
|---|---|
| 2025-07-28 | $4.60M 10-Q · filed 2025-11-05 |
| 2025-07-24 | $4.60M 10-K · filed 2026-02-23 |
| 2025-04-07 | $200.00K 10-K · filed 2026-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |